Heron Therapeutics, Inc. (HRTX) Ownership

$1.79

north_east
$0.13 (7.83%)
Day's range
$1.64
Day's range
$1.83

Heron Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RUBRIC CAPITAL MANAGEMENT LP 02/14/2025 26.71 M $40.87 M   0.00% 17.48%
BLACKROCK FUNDING, INC. /DE 02/07/2025 8.59 M $13.14 M   0.66% 5.62%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 8.50 M $13.01 M   -3.95% 5.56%
VANGUARD GROUP INC 02/11/2025 8.16 M $12.48 M   -6.45% 5.34%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 02/14/2025 6.99 M $10.69 M   0.00% 4.57%
TEJARA CAPITAL LTD 02/10/2025 4.66 M $7.13 M   -12.14% 3.05%
PALISADE CAPITAL MANAGEMENT, LP 02/14/2025 3.93 M $6.01 M   -1.65% 2.57%
D. E. SHAW & CO., INC. 02/14/2025 3.72 M $5.70 M   -15.07% 2.44%
STATE STREET CORP 02/14/2025 3.15 M $4.81 M   -1.45% 2.06%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 3.08 M $4.71 M   100.00% 2.01%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 3.02 M $4.61 M   -0.99% 1.97%
CONGRESS PARK CAPITAL LLC 01/15/2025 2.46 M $3.76 M   24.14% 1.61%
JW ASSET MANAGEMENT, LLC 02/07/2025 2.29 M $3.51 M   0.00% 1.50%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 2.14 M $3.27 M   15.69% 1.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 1.94 M $2.97 M   4,731.09% 1.27%
ORCHARD CAPITAL MANAGEMENT, LLC 02/14/2025 1.88 M $2.84 M   -5.24% 1.23%
CLEARLINE CAPITAL LP 02/14/2025 1.81 M $2.77 M   -18.69% 1.18%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 1.32 M $2.02 M   3.21% 0.86%
MONACO ASSET MANAGEMENT SAM 02/10/2025 1.21 M $1.86 M   -27.74% 0.79%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 1.19 M $1.82 M   -40.80% 0.78%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.11 M $1.69 M   0.86% 0.72%
MARSHALL WACE, LLP 02/13/2025 1.02 M $1.56 M   -40.69% 0.67%
TWO SIGMA INVESTMENTS, LP 02/14/2025 990,169 $1.51 M   -29.38% 0.65%
TWO SIGMA ADVISERS, LP 02/14/2025 823,871 $1.26 M   1.54% 0.54%
STONEPINE CAPITAL MANAGEMENT, LLC 02/14/2025 700,000 $1.07 M   100.00% 0.46%
CM MANAGEMENT, LLC 02/07/2025 700,000 $1.07 M   40.00% 0.46%
GOLDMAN SACHS GROUP INC 02/11/2025 655,160 $1.00 M   -61.62% 0.43%
RICHMOND BROTHERS, INC. 02/11/2025 642,339 $982,779   25.76% 0.42%
JPMORGAN CHASE & CO 02/12/2025 562,764 $861,029   172.25% 0.37%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 488,122 $746,826   -1.63% 0.32%
NEXPOINT ASSET MANAGEMENT, L.P. 02/14/2025 475,750 $727,898   0.00% 0.31%
QUINN OPPORTUNITY PARTNERS LLC 02/13/2025 380,000 $581,400   100.00% 0.25%
BANK OF NEW YORK MELLON CORP 02/04/2025 340,710 $521,287   -0.01% 0.22%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 314,275 $480,841   -71.60% 0.21%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 300,000 $459,000   100.00% 0.20%
XTX TOPCO LTD 02/13/2025 297,485 $455,152   -0.03% 0.19%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 277,344 $424,336   0.51% 0.18%
J. GOLDMAN & CO LP 02/14/2025 270,100 $413,253   100.00% 0.18%
APEIRON RIA LLC 01/17/2025 262,542 $401,689   7.80% 0.17%
BARCLAYS PLC 02/13/2025 241,346 $370,000   10.48% 0.16%
MILLENNIUM MANAGEMENT LLC 02/14/2025 215,531 $329,762   -76.93% 0.14%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 214,957 $328,884   -76.12% 0.14%
ALLIANCEBERNSTEIN L.P. 02/12/2025 198,550 $303,782   0.00% 0.13%
FMR LLC 02/13/2025 191,886 $293,586   -55.57% 0.13%
RHUMBLINE ADVISERS 01/30/2025 177,681 $271,837   1.08% 0.12%
UBS GROUP AG 02/14/2025 159,476 $243,998   87.06% 0.10%
RAYMOND JAMES FINANCIAL INC 02/13/2025 135,722 $207,655   100.00% 0.09%
ZWEIG-DIMENNA ASSOCIATES LLC 01/21/2025 128,592 $196,746   0.00% 0.08%
ANFIELD CAPITAL MANAGEMENT, LLC 02/05/2025 118,976 $182,033   5.56% 0.08%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 113,560 $173,747   10.63% 0.07%

Heron Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 256 institutional investors and hedge funds held shares of Heron Therapeutics, Inc.. The most heavily invested institutionals were:

Rubric Capital Management LP: 26.71 M

BlackRock Funding, Inc. /DE: 8.59 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 8.5 M

VANGUARD GROUP INC: 8.16 M

Velan Capital Investment Management LP: 6.99 M

Tejara Capital Ltd: 4.66 M

75.22% of Heron Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 136.63 M shares in the last 24 months. This purchase volume represents approximately $244.57 M in transactions.